EGFR mutations detected in plasma are associated with patient outcomes in erlotinib plus docetaxel-treated non-small cell lung cancer (Q43249950)
Jump to navigation
Jump to search
scientific article published in December 2009
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | EGFR mutations detected in plasma are associated with patient outcomes in erlotinib plus docetaxel-treated non-small cell lung cancer |
scientific article published in December 2009 |
Statements
1 reference
EGFR mutations detected in plasma are associated with patient outcomes in erlotinib plus docetaxel-treated non-small cell lung cancer (English)
1 reference
1 reference
David R Gandara
1 reference
Philip C Mack
1 reference
William S Holland
1 reference
Rebekah A Burich
1 reference
Randeep Sangha
1 reference
Leslie J Solis
1 reference
Yueju Li
1 reference
Primo N Lara
1 reference
Angela M Davies
1 reference
1 December 2009
1 reference
1 reference
Identifiers
1 reference